Dorsey Wright & Associates’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,375	Closed	-$28.1K	–	295
2023 Q2	$28.1K	Buy	1,375 +138	+11%	+$2.82K	0.01%	188
2023 Q1	$27.1K	Sell	1,237 -138	-10%	-$3.02K	0.01%	172
2022 Q4	$22.5K	Buy	+1,375	New	+$22.5K	0.01%	240